Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. This evidence concerns the gene DICER1 and DICER1-related tumor predisposition.